JMJD6 and neoplasm: Measurements of the tumor growth over a period of 6 wk showed that all HCT116 p53−/− xenografts grew significantly larger than HCT116 p53+/+ transplants, regardless of the infection of control siRNA or JMJD6 siRNAs (Figure 4E and Figure S8).